Inhibition of AMPK activation in Echinococcus granulosus sensu stricto limits the parasite’s glucose metabolism and survival
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01202-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Mingzhi Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The Fi…. Hauptthemen laut MEDLINE: Echinococcus granulosus, Parasites, Echinococcosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Natural Science Foundation of Xinjiang Uygur Autonomous Region for Distinguished Young Scholars, National Natural Science Foundation of China (NSFC), The Special Funds for Development of Local Science and Technology from Central Government.
Abstract (Originalsprache)
Cystic echinococcosis (CE) is a zoonotic parasitic disease caused by larvae of the Echinococcus granulosus sensu lato (s.l.) cluster. There is an urgent need to develop new drug targets and drug molecules to treat CE. Adenosine monophosphate (AMP)-activated protein kinase (AMPK), a serine/threonine protein kinase consisting of α, β, and γ subunits, plays a key role in the regulation of energy metabolism. However, the role of AMPK in regulating glucose metabolism in E. granulosus s.l. and its effects on parasite viability is unknown. In this study, we found that targeted knockdown of EgAMPKα or a small-molecule AMPK inhibitor inhibited the viability of E. granulosus sensu stricto (s.s.) and disrupted the ultrastructure. The results of in vivo experiments showed that the AMPK inhibitor had a significant therapeutic effect on E. granulosus s.s.-infected mice and resulted in the loss of cellular structures of the germinal layer. In addition, the inhibition of the EgAMPK/EgGLUT1 pathway limited glucose uptake and glucose metabolism functions in E. granulosus s.s.. Overall, our results suggest that EgAMPK can be a potential drug target for CE and that inhibition of EgAMPK activation is an effective strategy for the treatment of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.
- Anhui University, Hefei, China.
- Basic Medical College, Xinjiang Medical University, Urumqi, China.
- College of Pharmacy, Xinjiang Medical University, Urumqi, China.
ORCID-Profile: Mingzhi Yan, Renyong Lin, Guodong Lü
Förderung
- The Natural Science Foundation of Xinjiang Uygur Autonomous Region for Distinguished Young Scholars
- National Natural Science Foundation of China (NSFC)
- The Special Funds for Development of Local Science and Technology from Central Government
- The University synergy Innovation Program of Anhui Province
Zitieren
APA
Yan, M., Liu, H., Su, Y., Bi, X., Yang, N., Lin, R., & Lü, G. (2024). Inhibition of AMPK activation in Echinococcus granulosus sensu stricto limits the parasite’s glucose metabolism and survival. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01202-23
Vancouver
Yan M, Liu H, Su Y, Bi X, Yang N, Lin R, et al. Inhibition of AMPK activation in Echinococcus granulosus sensu stricto limits the parasite’s glucose metabolism and survival. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01202-23
BibTeX
@article{Yan2024,
author = {Yan, Mingzhi and Liu, Hui and Su, Yansen and Bi, Xiaojuan and Yang, Ning and Lin, Renyong and Lü, Guodong},
title = {Inhibition of AMPK activation in Echinococcus granulosus sensu stricto limits the parasite’s glucose metabolism and survival},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01202-23}
}
EUVIMED